This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crea, F. Articles by Maseri, A. Search for Related Content PubMed PubMed Citation Articles by Crea, F. Articles by Maseri, A.

Circulation, Vol 74, 262-269, Copyright © 1986 by American Heart Association

ARTICLES

Provocation of coronary spasm by dopamine in patients with active variant angina pectoris

F Crea, S Chierchia, JC Kaski, GJ Davies, A Margonato, DO Miran and A Maseri

The effects of dopamine on arteries are different depending on the dose, route of administration, and receptor population. Its administration can cause vasodilation by stimulation of dopaminergic receptors, vasoconstriction by stimulation of alpha-adrenergic and serotonergic receptors, and even spasm of cerebral arteries when given intracisternally in dogs. The ability of dopamine to provoke coronary spasm was assessed in 18 patients with active vasospastic angina in whom this amine was infused at rates of 5, 10, and 15 micrograms/kg/min for periods of 5 min each. The 12-lead electrocardiogram and blood pressure (cuff) were monitored throughout the whole test. In nine patients dopamine caused angina and ischemic electrocardiographic changes suggestive of coronary spasm: ST segment elevation in six patients and ST segment depression in the absence of important coronary stenoses in the remaining three. Infusion of dopamine was repeated during coronary angiography in three patients with positive test results: this provoked occlusive coronary spasm with ST segment elevation in two patients and nonocclusive spasm with ST segment depression in the remainder. In conclusion, infusion of dopamine provokes coronary spasm in a sizeable proportion of patients with active vasospastic angina. Its administration may be detrimental in patients susceptible to coronary spasm, such as those with acute myocardial infarction.

This article has been cited by other articles:

				N. Miyai, T. Kawasaki, H. Sugihara, and R. Kayo Coronary Artery Spasm as a Cause of Droperidol-Induced Ventricular Fibrillation Anesth. Analg., December 1, 2006; 103(6): 1602 - 1603. [Full Text] [PDF]

				P. K. Mishra Variations in presentation and various options in management of variant angina. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 748 - 759. [Abstract] [Full Text] [PDF]

				T. Tomaru, Y. Uchida, H. Sonoki, M. Tsukamoto, and T. Sugimoto The Thrombolytic Effects of Native Tissue-Type Plasminogen Activator (AK-124) on Experimental Canine Coronary Thrombosis Angiology, May 1, 1989; 40(5): 429 - 435. [Abstract] [PDF]